€4.5M+ from KWF Kankerbestrijding • Lumox
The clinical countdown has started. Are you in? Lumox, one of our startups, just secured €4.5M+ from KWF Kankerbestrijding to fund the first clinical study of their light-activated precision cancer therapy. The roadmap to patients is now a timeline.